HIV-1 Vaccine
Novel HIV vaccine candidate found safe and responsive
New research published in The Lancet shows that an experimental HIV-1 vaccine regimen is well-tolerated and generated comparable and robust immune responses against HIV in healthy adults and rhesus monkeys.
July 8, 2018
Novel HIV vaccine candidate found safe and responsive
New research published in The Lancet shows that an experimental HIV-1 vaccine regimen is well-tolerated and generated comparable and robust immune responses against HIV in healthy adults and rhesus monkeys.
X